Suppr超能文献

单肾患者肾细胞癌的血管内治疗:一项病例报告研究。

Endovascular management of RCC in one-kidney patient: a case report study.

作者信息

Ghareeb Amjad, Salameh Bairak, Halaweh Malaz, Al-Tawil Muhamad, Nahas Mohammed Ali

机构信息

Faculty of Medicine, Damascus University, Damascus, Syria.

Urology Department, Al-Mouwasat University Hospital, Damascus University, Damascus, Syria.

出版信息

Ann Med Surg (Lond). 2023 Apr 1;85(5):2108-2111. doi: 10.1097/MS9.0000000000000559. eCollection 2023 May.

Abstract

UNLABELLED

Renal cell carcinoma is considered one of the most common and deadly cancers, which remain asymptomatic until the late stage, needing total nephrectomy when it is detected. In mono-kidney patients this will lead to hemodialysis and later a kidney transplant.

CASE PRESENTATION

This case represents our center's experience and strategy in managing renal cell carcinoma in a one-kidney patient by endovascular management first followed by partial nephrectomy.

CLINICAL DISCUSSION

The patient's postoperative follow-up has a good quality of life with no signs of tumor recurrence or metastasis in addition to normal kidney functions tests.

CONCLUSION

Preoperative endovascular intervention can represent a good and accepted solution for a partial nephrectomy preserving not only a normal renal function, without the need for kidney transplantation, but also a good quality of life.

摘要

未标注

肾细胞癌被认为是最常见且致命的癌症之一,在晚期之前通常没有症状,一旦被发现就需要进行全肾切除术。对于单肾患者,这将导致血液透析,随后还需要进行肾移植。

病例介绍

本病例展示了我们中心在处理单肾患者肾细胞癌时的经验和策略,首先采用血管内治疗,随后进行部分肾切除术。

临床讨论

患者术后随访显示生活质量良好,除肾功能检查正常外,无肿瘤复发或转移迹象。

结论

术前血管内介入可为部分肾切除术提供一个良好且被认可的解决方案,不仅能保留正常肾功能,无需肾移植,还能保证良好的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da9/10205279/1fedca4c930c/ms9-85-2108-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验